Several trials have examined modified and unmodified tetracyclines for the treatment of human cancers; of those, very promising results were achieved with CMT-3 for patients with Kaposi Sarcoma.
Realizáronse varios ensaios sobre tetraciclinas modificadas e non modificadas para o tratamento de cánceres humanos, nos cales se obtiveron resultados prometedores co CMT-3 en pacientes con sarcoma de Kaposi.